GGHCX vs. FBTTX
Compare and contrast key facts about Invesco Health Care Fund (GGHCX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX).
GGHCX is managed by Invesco. It was launched on Aug 6, 1989. FBTTX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
GGHCX vs. FBTTX - Performance Comparison
Loading graphics...
GGHCX vs. FBTTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GGHCX Invesco Health Care Fund | -6.17% | 15.48% | 3.96% | 3.05% | -13.53% | 12.05% | 14.52% | 32.01% | 0.27% | 15.51% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 2.18% | 39.21% | 5.08% | 10.43% | -8.22% | -3.35% | 31.82% | 25.39% | -4.19% | 25.37% |
Returns By Period
In the year-to-date period, GGHCX achieves a -6.17% return, which is significantly lower than FBTTX's 2.18% return. Over the past 10 years, GGHCX has underperformed FBTTX with an annualized return of 7.04%, while FBTTX has yielded a comparatively higher 11.54% annualized return.
GGHCX
- 1D
- 2.71%
- 1M
- -5.49%
- YTD
- -6.17%
- 6M
- -0.07%
- 1Y
- 5.67%
- 3Y*
- 6.01%
- 5Y*
- 2.87%
- 10Y*
- 7.04%
FBTTX
- 1D
- 5.09%
- 1M
- -0.77%
- YTD
- 2.18%
- 6M
- 15.39%
- 1Y
- 55.03%
- 3Y*
- 20.14%
- 5Y*
- 8.63%
- 10Y*
- 11.54%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
GGHCX vs. FBTTX - Expense Ratio Comparison
GGHCX has a 1.04% expense ratio, which is lower than FBTTX's 1.28% expense ratio.
Return for Risk
GGHCX vs. FBTTX — Risk / Return Rank
GGHCX
FBTTX
GGHCX vs. FBTTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Health Care Fund (GGHCX) and Fidelity Advisor Biotechnology Fund Class M (FBTTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| GGHCX | FBTTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.29 | 1.92 | -1.63 |
Sortino ratioReturn per unit of downside risk | 0.51 | 2.52 | -2.00 |
Omega ratioGain probability vs. loss probability | 1.06 | 1.32 | -0.26 |
Calmar ratioReturn relative to maximum drawdown | 0.29 | 3.13 | -2.84 |
Martin ratioReturn relative to average drawdown | 0.92 | 12.48 | -11.56 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| GGHCX | FBTTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 1.92 | -1.63 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.19 | 0.37 | -0.19 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.47 | -0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.57 | 0.30 | +0.27 |
Correlation
The correlation between GGHCX and FBTTX is 0.79, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
GGHCX vs. FBTTX - Dividend Comparison
GGHCX's dividend yield for the trailing twelve months is around 6.06%, more than FBTTX's 1.50% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GGHCX Invesco Health Care Fund | 6.06% | 5.69% | 5.17% | 0.00% | 0.00% | 24.69% | 6.44% | 3.51% | 8.81% | 6.88% | 2.24% | 15.07% |
FBTTX Fidelity Advisor Biotechnology Fund Class M | 1.50% | 1.53% | 6.41% | 0.93% | 0.00% | 21.60% | 8.79% | 7.10% | 2.64% | 0.00% | 0.00% | 5.42% |
Drawdowns
GGHCX vs. FBTTX - Drawdown Comparison
The maximum GGHCX drawdown since its inception was -40.23%, smaller than the maximum FBTTX drawdown of -63.75%. Use the drawdown chart below to compare losses from any high point for GGHCX and FBTTX.
Loading graphics...
Drawdown Indicators
| GGHCX | FBTTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.23% | -63.75% | +23.52% |
Max Drawdown (1Y)Largest decline over 1 year | -13.53% | -13.58% | +0.05% |
Max Drawdown (5Y)Largest decline over 5 years | -25.37% | -36.64% | +11.27% |
Max Drawdown (10Y)Largest decline over 10 years | -29.34% | -39.04% | +9.70% |
Current DrawdownCurrent decline from peak | -10.60% | -2.61% | -7.99% |
Average DrawdownAverage peak-to-trough decline | -8.82% | -21.95% | +13.13% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.35% | 3.72% | +0.63% |
Volatility
GGHCX vs. FBTTX - Volatility Comparison
The current volatility for Invesco Health Care Fund (GGHCX) is 5.53%, while Fidelity Advisor Biotechnology Fund Class M (FBTTX) has a volatility of 9.37%. This indicates that GGHCX experiences smaller price fluctuations and is considered to be less risky than FBTTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| GGHCX | FBTTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.53% | 9.37% | -3.84% |
Volatility (6M)Calculated over the trailing 6-month period | 9.39% | 17.02% | -7.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.87% | 25.99% | -10.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.52% | 23.31% | -7.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.51% | 24.58% | -7.07% |